B_HHS OPA FPAR 2.0 Data Elements 5.4.21.xlsx

Family Planning Annual Report 2.0

B_HHS OPA FPAR 2.0 Data Elements 5.4.21.xlsx

OMB: 0990-0479

⚠️ Notice: This form may be outdated. More recent filings and information on OMB 0990-0479 can be found here:

2022-01-10 - Revision of a currently approved collection

Document [xlsx]

Download: xlsx | pdf

Overview

Introduction
FPAR 2.0 Data Elements
PAP Smear Tests Panel (86662-4)
HPV Tests Panel (86658-2)
Chlamydia Tests Panel (86659-0)
Neis. Gonorrhea Panel (86660-8)
CT+NG Com Tests Panel (86661-6)
HIV 1 & 2 Tests Panel (86657-4)

Sheet 1: Introduction

		Form Approved
		OMB No. 0990-XXXX
		Exp. Date XX/XX/20XX


	FPAR 2.0 Data Elements
	These are the final FPAR 2.0 data elements and associated lab panels. Additional tools are being developed to provide further implementation guidance. Please direct questions to your project officer.











	Version: 5/4/2021

	According to the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number. The valid OMB control number for this information collection is 0990-xxxx. The time required to complete this information collection is estimated to average 102 hours per response, including the time to review instructions, search existing data resources, gather the data needed, to review and complete the information collection. If you have comments concerning the accuracy of the time estimate(s) or suggestions for improving this form, please write to: U.S. Department of Health & Human Services, OS/OCIO/PRA, 200 Independence Ave., S.W., Suite 336-E, Washington D.C. 20201, Attention: PRA Reports Clearance Officer

Sheet 2: FPAR 2.0 Data Elements

Data Element #	FPAR 2.0 Data Element (Long Common Name)	In FPAR Panel?	Data Element Code (If Available)	Standard Terminology Code System	Term Description	Answer List Name / Description (Value Set)	Answer List	Value Set Code (If available)	Notes	eCQM	Modified Contraceptive Care Measures
-	Family Planning Annual Report PANEL	-	86636-8	LOINC SNOMEDCT CDCREC	This panel contains the set of LOINC codes for data elements in the Family Planning Annual Report and Health Information Technology (Health IT) (FPAR 2.0) specification. The FPAR 2.0 set includes both patient-level panels containing individual terms to capture specific data elements, as well as convenience group panels that contain sets of LOINC codes (e.g., the set of LOINC codes representing pregnancy tests), from which one or more codes may be used to gather results for a specific data element. Annual submission of the FPAR 2.0 to the U.S. Department of Health and Human Services, Office of Population Affairs (OPA) is required for all sites participating in the Title X National Family Planning Program.	-	-	-	LOINC Panels are collections of LOINC terms that represent specific sets of information, such as a laboratory battery of tests, a group of findings from a procedure such as an EKG, and forms or assessments related to health that are completed by patients and/or providers. LOINC Panels contain a specific structure, and depending on the type of panel, can include attributes such as form coding instructions, skip logic, and nested panels.
1	Facility Identifier	Y	75524-9	LOINC	A code that identifies a hospital or clinic. The facility ID may be a true identifier (e.g. Facility NPI) or a pseudo-identifier.	Not applicable	Not applicable	Not applicable	OPA intends to collect NPI 2, when possible. Further guidance to be developed	x	x
2	Attending physician NPI Provider	Y	68468-8	LOINC	-	NPI / National Provider Identifier - NPI	Not applicable (Answer list code provided because code is normative)	LL512-5		x	x
3	Provider Role	Y	86637-6	LOINC	The role of the clinical provider (e.g. doctor, registered nurse) that provided services at the encounter.	Provider role / Example list of provider role types	Doctor Registered Nurse Midwife Nurse Practitioner Physician Assistant Physical Therapist Physical Therapist Assistant Other Student Physical therapist Student Physical therapy assistant	LL4575-8			x
4	Patient Identifier	Y	76435-7	LOINC	The patient identifier is a unique alphanumeric string that identifies a specific patient and is assigned by a specific organization (the assigning authority) that should be reported using [LOINC: 76698-0]. In HL7 v2 messages, the patient identifier is reported in PID-3.1 and the assigning authority in PID-3.4. Examples of patient identifiers are medical record number, driver's license number and Social Security number, and their corresponding assigning authorities are the appropriate healthcare facility, state motor vehicle administration and the Social Security Administration, respectively.	Not applicable	Not applicable	Not applicable	Implementation guidance to be developed to maximize client confidentiality. OPA will NOT collect identifiers such as social security number or driver's license number.	x	x
5	Visit Date	Y	76427-4	LOINC	Visit date	Not applicable	Not applicable	Not applicable		x	x
6	Birth Date	Y	21112-8	LOINC	Client’s date of birth	Not applicable	Not applicable	Not applicable		x	x
7	Sex	Y	46098-0	LOINC	In LOINC, sex refers to the biological sex of an organism, which is most commonly determined based on anatomy and physiology or genetic (chromosome) analysis. Our definition is based on the World Health Organization's definition of sex and gender: sex (male, female) refers to biological and physiological characteristics, and gender (masculine, feminine) refers to socially constructed roles, behaviors, activities, and attributes.	Gender_M/F / Male=1, Female=2	Male Female	LL1-9		x	x
8	Limited English Proficiency	Y	86640-0	LOINC	This concept indicates whether the patient has limited English proficiency and may require care delivery in a language other than the English.	Proficient in English\|Not proficient in English / Proficient or not proficient in English	Proficient in English Not Proficient in English	LL4682-2
9	Ethnicity	Y	69490-1	LOINC	This term is used for reporting the ethnicity based on classifications provided by the Office of Management and Budget (OMB), Revisions to the Standards for the Classification of Federal Data on Race and Ethnicity (Oct. 30, 1997).	Ethnicity OMB 1997 / Answer list for ethnicity based on OMB 1997 Revisions to the Standards for the Classification of Federal Data on Race and Ethnicity	Hispanic or Latino Not Hispanic or Latino	LL2361-5		x	x
10	Race	Y	32624-9	LOINC	Race as defined by the Office of Management and Budget (OMB).	Race or Unknown / OMB 1997 race categories plus Unknown	American Indian or Alaska Native Asian Black or African American Native Hawaiian or Other Pacific Islander White Unknown	LL2858-0		x	x
11	Household Income	N			Combined family income for last year before taxes; Family is 1 person or 2 or more persons living together as a household.	-	-	-			x
12	Household size [#]	Y	86639-2	LOINC	Number in household; family is 1 person or 2 or more persons living together as a household.	Not applicable	Not applicable	Not applicable			x
13	Insurance Coverage Type	Y	87520-3	LOINC	A high level description of a patient's health coverage type, including various categories of insurance (public, private, etc.) and self-pay. To report the specific source(s) of payment for a health care product or service, use Payment sources [LOINC: 52556-8].	Coverage Type and Self-Pay Codes / A value set includes Coverage Type codes	Pay extended healthcare health spending account automobile collision coverage policy uninsured motorist policy public healthcare dental program public health program women's cancer detection program end renal program HIV-AIDS program mandatory health program mental health program safety net clinic program substance use program subsidized health program subsidized managed care program subsidized supplemental health program worker's compensation dental care policy disease specific policy drug policy health insurance plan policy long term care policy managed care policy point of service policy health maintenance organization policy preferred provider organization policy mental health policy substance use policy vision care policy disability insurance policy employee welfare benefit plan policy flexible benefit plan policy life insurance policy annuity policy term life insurance policy universal life insurance policy property and casualty insurance policy reinsurance policy surplus line insurance policy umbrella liability insurance policy charity program crime victim program employee assistance program government employee health program high risk pool program indigenous peoples health program military health program retiree health program social service program veteran health program	LL4668-1			x
14	Payer for Visit	Y	52556-8	LOINC	Current payment sources	Coverage Type and Self-Pay Codes / A value set includes Coverage Type codes	None (no charge for current services) Medicare (traditional fee-for-service) Medicare (HMO/managed care) Medicaid (traditional fee-for-service) Medicaid (HMO/managed care) Workers’ compensation Title programs (e.g., Title III, V, or XX) Other government (e.g., TRICARE, VA, etc.) Private insurance/Medigap Private HMO/managed care Self-pay Other (specify) Unknown	LL544-8			x
15	Pregnancy Status	Y	82810-3	LOINC	This term should be used to indicate that the patient is currently pregnant, not pregnant, or that the pregnancy status is unknown at this time. Depending on the context in which this term is used, there may be a need to capture more granular information. For example, further information such as whether the pregnancy is planned or unplanned and whether the status is patient reported or test confirmed may be necessary.	Pregnant\|Not pregnant\|Unknown / Answers: 3; Scale: Nom; Code: -; Score: -	Pregnant Not Pregnant Unknown	LL4129-4		x	x
16	Pregnancy Intention	Y	86645-9	LOINC	A patient's intention or desire in the next year to either become pregnant or prevent a future pregnancy. This includes male patients seeking pregnancy with a female partner. Pregnancy intention may be used to help improve preconception health screenings and decisions, such as determining an appropriate contraceptive method, taking folic acid, or avoiding toxic exposures such as alcohol, tobacco and certain medications.	Yes\|OK either way\|No\|Unsure / Answers: 4; Scale: Nom; Code: -; Score: -	Yes, I want to become pregnant I'm OK either way No, I don't want to become pregnant Unsure	LL4053-6			x
17	Contraceptive method at intake reported – at intake	Y	86649-1	LOINC	At intake of patient encounter, their reported contraceptive method(s) used in the last sexual encounter.	Birth control methods / List of contraceptive methods	Implantable rod IUD with Progestin IUD copper IUD unspecified Female sterilization Vasectomy Injectables Combined oral contraceptive pills Progestin only contraceptive pills Contraceptive patch Vaginal ring Male condom Diaphragm or cervical cap Female condom Withdrawal Spermicide Sponge Fertility awareness-based methods Lactational amenorrhea method Male relying on female method Emergency contraception Decline to answer None	LL4578-2	Used for electronic clinical quality measure and modified contraceptive care measure calculations. More guidance to follow.	x	x
18	Reason for no contraceptive method use Reported --at intake	Y	86650-9	LOINC	At intake of patient encounter, the reason the patient reported no contraceptive method used.	Reason for no birth control / Example list of reasons for why birth control (contraceptive methods) is not used	Abstinence Same sex partner Other Sterile for non-contraceptive reasons Seeking pregnancy	LL4579-0	Used for modified contraceptive care measure calculations. More guidance to follow.		x
19	Contraceptive method at exit reported – at exit	Y	86651-7	LOINC	The contraceptive method(s) provided to or in use by the patient at the end of their visit after counseling and assessment by provider.	Birth control methods / List of contraceptive methods	Implantable rod IUD with Progestin IUD copper IUD unspecified Female sterilization Vasectomy Injectables Combined oral contraceptive pills Progestin only contraceptive pills Contraceptive patch Vaginal ring Male condom Diaphragm or cervical cap Female condom Withdrawal Spermicide Sponge Fertility awareness-based methods Lactational amenorrhea method Male relying on female method Emergency contraception Decline to answer None	LL4578-2	Similar to Table 7 in FPAR 1.0, continue to be reported in FPAR 2.0. Also used for the modified contraceptive care measure calculations.	x	x
20	Reason for no contraceptive method use reported –at exit	Y	86653-3	LOINC	The reported reason at the end of the patient's visit for not using a contraceptive method(s).	Reason for no birth control / Example list of reasons for why birth control (contraceptive methods) is not used	Abstinence Same sex partner Other Sterile for non-contraceptive reasons Seeking pregnancy	LL4579-0	Similar to Table 7 in FPAR 1.0, continue to be reported in FPAR 2.0. Also used for the modified contraceptive care measure calculations.		x
21	How birth control method was provided	Y	86652-5	LOINC	The method for how the birth control was provided (e.g. on site, referral, prescription) to the patient at end of an encounter.	Method for providing birth control / Example for how birth control method was provided to the patient	Provided on site Referral Prescription	LL4580-8	Used for modified contraceptive care measure calculations. More guidance to follow.		x
22	Contraceptive counseling was provided	Y	86654-1	LOINC	Contraceptive counseling is an interaction in which provider spends time (5-10 minutes) during an encounter discussing the patient's choice of contraceptive method and available options.	[HL7-0136] Yes\|No / Answers: 2; Scale: Ord; Code: Y-N; Score: -	Yes No	LL365-8	Used for modified contraceptive care measure calculations. More guidance to follow.		x
23	Counseling to achieve pregnancy was provided	Y	86655-8	LOINC	Counseling to achieve pregnancy is an interaction in which a provider spends time during an encounter discussing any services and/or provides counseling related to achieving pregnancy or addressing infertility.	[HL7-0136] Yes\|No / Answers: 2; Scale: Ord; Code: Y-N; Score: -	Yes No	LL365-8	Used for modified contraceptive care measure calculations. More guidance to follow.		x
24	Systolic blood pressure	Y	8480-6	LOINC	Systolic blood pressure. If multiple values exist, choose last one during that encounter.	Not applicable	Not applicable	Not applicable
25	Diastolic blood pressure	Y	8462-4	LOINC	Diastolic blood pressure. If multiple values exist, choose last one during that encounter.	Not applicable	Not applicable	Not applicable
26	Body Height	Y	8302-2	LOINC	Height	Not applicable	Not applicable	Not applicable
27	Body Weight	Y	29463-7	LOINC	Body Weight	Not applicable	Not applicable	Not applicable
28	Tobacco Smoking Status	Y	72166-2	LOINC	Tobacco smoking status represents a person's smoking behavior. Smoking statuses can be classified as current every day smoker, current some day smoker, former smoker, never smoker, smoker - current status unknown, unknown if ever smoked, current heavy tobacco smoker, and current light tobacco smoker. These statuses represent CDC's preferred (sometimes required) responses for recording smoking status.	Smoking Status - HL7 Value Set / Value Set based on HL7 Vocab TC and Structured Doc consensus (per CDC submission 7/12/2012 for smoking status term)	Current every day smoker Current some day smoker Former smoker Never smoker Smoker, current status unknown Unknown if ever smoked Heavy tobacco smoker Light tobacco smoker	LL2201-3
29	Pap test performed at this visit	N	-	-	A pap test was performed during the visit.	[HL7-0136] Yes\|No / Answers: 2; Scale: Ord; Code: Y-N; Score: -	Yes No	LL365-8
30	Pap test performed in last 5 years	N	-	-	A pap test has been performed during the last 5 years.	[HL7-0136] Yes\|No / Answers: 2; Scale: Ord; Code: Y-N; Score: -	Yes No	LL365-8
31	Pap smear tests - FPAR 2.0 set (PANEL)	Y	86662-4	LOINC	Set of lab terms that may be used to gather Pap smear test results at time of the patient encounter as specified by the Family Planning Annual Report (FPAR).	-	-	-	This data element is a panel set - see TAB 86662-4, further guidance to be developed to reduce reporting burden of lab values.
32	HPV test performed at this visit	N	-	-	An HPV test was performed during the visit.	[HL7-0136] Yes\|No / Answers: 2; Scale: Ord; Code: Y-N; Score: -	Yes No	LL365-8
33	HPV tests - FPAR 2.0 set (PANEL)	Y	86658-2	LOINC	Set of lab terms that may be used to gather HPV test results at time of the patient encounter as specified by the Family Planning Annual Report (FPAR).	-	-	-	This data element is a panel set - see TAB 86662-4, further guidance to be developed to reduce reporting burden of lab values.
34	Chlamydia sp test performed at this visit	N	-	-	A Chlamydia test was performed during the visit.	[HL7-0136] Yes\|No / Answers: 2; Scale: Ord; Code: Y-N; Score: -	Yes No	LL365-8
35	Chlamydia sp tests - FPAR 2.0 set (PANEL)	Y	86659-0	LOINC	Set of lab terms that may be used to gather Chlamydia trachomatis test results at time of the patient encounter as specified by the Family Planning Annual Report (FPAR).	-	-	-	This data element is a panel set - see TAB 86659-0, further guidance to be developed to reduce reporting burden of lab values.
36	Neisseria gonorrhoeae test performed at this visit	N	-	-	A Neisseria gonorrhoeae test was performed during the visit.	[HL7-0136] Yes\|No / Answers: 2; Scale: Ord; Code: Y-N; Score: -	Yes No	LL365-8
37	Neisseria gonorrhoeae tests - FPAR 2.0 set (PANEL)	Y	86660-8	LOINC	Set of lab terms that may be used to gather Neisseria gonorrhoeae test results at time of the patient encounter as specified by the Family Planning Annual Report (FPAR).	-	-	-	This data element is a panel set - see TAB 86660-8, further guidance to be developed to reduce reporting burden of lab values.
38	HIV test performed at this visit	N	-	-	An HIV test was performed during the visit.	[HL7-0136] Yes\|No / Answers: 2; Scale: Ord; Code: Y-N; Score: -	Yes No	LL365-8
39	HIV 1 and 2 tests - FPAR 2.0 set (PANEL)	Y	86657-4	LOINC	Set of lab terms that may be used to gather HIV 1 & 2 test results at time of the patient encounter as specified by the Family Planning Annual Report (FPAR).	-	-	-	This data element is a panel set - see TAB 86660-8, further guidance to be developed to reduce reporting burden of lab values.
40	Syphilis test performed at this visit	N	-	-	A Syphilis test was performed during the visit.	[HL7-0136] Yes\|No / Answers: 2; Scale: Ord; Code: Y-N; Score: -	Yes No	LL365-8
41	Syphilis Test Result	N	-	-	-	-	-	-	Panel to be updated, further guidance to be developed to reduce reporting burden of lab values.
42	Self-Identified Need for Contraception	N			A patient’s self-reported desire to discuss contraception at their visit. Can be asked to a person of any gender and should be asked minimum once per year. Can be asked alongside a patient's intention or desire in the next year to become pregnant.		Yes - I want to talk about contraception No - I don't want to talk about contraception (mark all that apply) • I'm here for something else • This question does not apply to me • I prefer not to answer • I'm already using contraception • I'm unsure or don't want to use contraception • I'm hoping to become pregnant in the near future		OPTIONAL for reporting. LOINC code pending. Used for the electronic clinical quality measure (eCQM) calculation in development at UCSF under a grant from OPA. Further guidance to follow.	x

Sheet 3: PAP Smear Tests Panel (86662-4)

Data Element #	FPAR 2.0 Term	In FPAR Panel (86636-8)?	Available Term Code (If Available)	Term Code System	Definition	Value Set (Response Options/Answer Lists)	Notes
-	Pap smear tests - FPAR 2.0 set (PANEL)	Y	86662-4	LOINC	Set of lab terms that may be used to gather Pap smear test results at time of the patient encounter as specified by the Family Planning Annual Report (FPAR).		LOINC Panels are collections of LOINC terms that represent specific sets of information, such as a laboratory battery of tests, a group of findings from a procedure such as an EKG, and forms or assessments related to health that are completed by patients and/or providers. LOINC Panels contain a specific structure, and depending on the type of panel, can include attributes such as form coding instructions, skip logic, and nested panels.
1	Microscopic observation [Identifier] in Cervix by Cyto stain	Y	10524-7	LOINC	Microscopy is a technique that uses microscopes to examine very small objects, not seen by the naked eye. There are three well-known branches of microscopy: optical, electron and scanning probe microscopy.
2	Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep	Y	18500-9	LOINC	Thin prep is an automated method of preparing the smear;cells are first treated/lysed to diminish obstructions such as blood, then spread very thinly by the machine.
3	Microscopic observation [Identifier] in Cervical or vaginal smear or scraping by Cyto stain	Y	19765-7	LOINC	Microscopy is a technique that uses microscopes to examine very small objects, not seen by the naked eye. There are three well-known branches of microscopy: optical, electron and scanning probe microscopy.
4	Microscopic observation [Identifier] in Cervical or vaginal smear or scraping by Cyto stain Narrative	Y	19766-5	LOINC	Microscopy is a technique that uses microscopes to examine very small objects, not seen by the naked eye. There are three well-known branches of microscopy: optical, electron and scanning probe microscopy.
5	Cytology study comment Cervical or vaginal smear or scraping Cyto stain	Y	19774-9	LOINC
6	Cytology Cervical or vaginal smear or scraping study	Y	33717-0	LOINC	Document that is generated in response to a request.
7	Cytology report of Cervical or vaginal smear or scraping Cyto stain.thin prep	Y	47527-7	LOINC
8	Cytology report of Cervical or vaginal smear or scraping Cyto stain	Y	47528-5	LOINC
9	General categories [Interpretation] of Cervical or vaginal smear or scraping by Cyto stain	Y	19762-4	LOINC
10	Statement of adequacy [Interpretation] of Cervical or vaginal smear or scraping by Cyto stain	Y	19764-0	LOINC

Sheet 4: HPV Tests Panel (86658-2)

Data Element #	FPAR 2.0 Term	In FPAR Panel (86636-8)?	Available Term Code (If Available)	Term Code System	Definition	Value Set (Response Options/Answer Lists)	Notes
-	HPV tests - FPAR 2.0 set (PANEL)	Y	86658-2	LOINC	Set of lab terms that may be used to gather HPV test results at time of the patient encounter as specified by the Family Planning Annual Report (FPAR).	-	LOINC Panels are collections of LOINC terms that represent specific sets of information, such as a laboratory battery of tests, a group of findings from a procedure such as an EKG, and forms or assessments related to health that are completed by patients and/or providers. LOINC Panels contain a specific structure, and depending on the type of panel, can include attributes such as form coding instructions, skip logic, and nested panels.
1	Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA	Y	59420-0	LOINC	Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by Probe with signal amplification
			59420-0	LOINC		Detected (qualifier value)
			260373001	SNOMEDCT		Not detected (qualifier value)
2	Human papilloma virus 16+18+31+33+35+45+51+52+56 DNA	Y	260415000	SNOMEDCT	Human papilloma virus 16+18+31+33+35+45+51+52+56 DNA [Presence] in Cervix by Probe
			21440-3	LOINC		Positive (qualifier value)
			10828004	SNOMEDCT		Negative (qualifier value)
3	Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA	Y	260385009	SNOMEDCT	Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe with signal amplification
			30167-1	LOINC		Positive (qualifier value)
			10828004	SNOMEDCT		Negative (qualifier value)
4	Human papilloma virus 6+11+16+18+31+33+35+39+42+43+44+45+51+52+56+58+59+68 DNA	Y	260385009	SNOMEDCT	Human papilloma virus 6+11+16+18+31+33+35+39+42+43+44+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe with signal amplification
			38372-9	LOINC		Positive (qualifier value)
			10828004	SNOMEDCT		Negative (qualifier value)
5	Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA	Y	260385009	SNOMEDCT	Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Unspecified specimen by NAA with probe detection
			49896-4	LOINC		Positive (qualifier value)
			10828004	SNOMEDCT		Negative (qualifier value)
6	Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 E6+E7 mRNA	Y	260385009	SNOMEDCT	Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
			69002-4	LOINC		Positive (qualifier value)
			10828004	SNOMEDCT		Negative (qualifier value)
7	Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+66 DNA	Y	260385009	SNOMEDCT	Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+66 DNA [Presence] in Tissue by Probe
			73959-9	LOINC		Positive (qualifier value)
			10828004	SNOMEDCT		Negative (qualifier value)
8	Human papilloma virus identified	Y	260385009	SNOMEDCT	Human papilloma virus identified in Cervix
			11083-3	LOINC		Positive (qualifier value)
			10828004	SNOMEDCT		Detected (qualifier value)
			260373001	SNOMEDCT		Negative (qualifier value)
			260385009	SNOMEDCT		Not detected (qualifier value)
			260415000	SNOMEDCT		Equivocal (qualifier value)
			42425007	SNOMEDCT		Indeterminate (qualifier value)
9	Human papilloma virus 16+18 Ag	Y	82334004	SNOMEDCT	Human papilloma virus 16+18 Ag [Presence] in Genital specimen
			12223-4	LOINC		Positive (qualifier value)
			10828004	SNOMEDCT		Detected (qualifier value)
			260373001	SNOMEDCT		Negative (qualifier value)
			260385009	SNOMEDCT		Not detected (qualifier value)
			260415000	SNOMEDCT		Equivocal (qualifier value)
			42425007	SNOMEDCT		Indeterminate (qualifier value)
10	Human papilloma virus 16+18 Ag	Y	82334004	SNOMEDCT	Human papilloma virus 16+18 Ag [Presence] in Cervix
			14503-7	LOINC		Positive (qualifier value)
			10828004	SNOMEDCT		Detected (qualifier value)
			260373001	SNOMEDCT		Negative (qualifier value)
			260385009	SNOMEDCT		Not detected (qualifier value)
			260415000	SNOMEDCT		Equivocal (qualifier value)
			42425007	SNOMEDCT		Indeterminate (qualifier value)
11	Human papilloma virus 16+18 Ag	Y	82334004	SNOMEDCT	Human papilloma virus 16+18 Ag [Presence] in Vaginal fluid
			14504-5	LOINC		Positive (qualifier value)
			10828004	SNOMEDCT		Detected (qualifier value)
			260373001	SNOMEDCT		Negative (qualifier value)
			260385009	SNOMEDCT		Not detected (qualifier value)
			260415000	SNOMEDCT		Equivocal (qualifier value)
			42425007	SNOMEDCT		Indeterminate (qualifier value)
12	Human papilloma virus 16+18 Ag	Y	82334004	SNOMEDCT	Human papilloma virus 16+18 Ag [Presence] in Urethra
			14506-0	LOINC		Positive (qualifier value)
			10828004	SNOMEDCT		Detected (qualifier value)
			260373001	SNOMEDCT		Negative (qualifier value)
			260385009	SNOMEDCT		Not detected (qualifier value)
			260415000	SNOMEDCT		Equivocal (qualifier value)
			42425007	SNOMEDCT		Indeterminate (qualifier value)
13	Human papilloma virus 16+18 Ag	Y	82334004	SNOMEDCT	Human papilloma virus 16+18 Ag [Presence] in Unspecified specimen
			17400-3	LOINC		Positive (qualifier value)
			10828004	SNOMEDCT		Detected (qualifier value)
			260373001	SNOMEDCT		Negative (qualifier value)
			260385009	SNOMEDCT		Not detected (qualifier value)
			260415000	SNOMEDCT		Equivocal (qualifier value)
			42425007	SNOMEDCT		Indeterminate (qualifier value)
14	Human papilloma virus DNA	Y	82334004	SNOMEDCT	Human papilloma virus DNA [Presence] in Cervix by Probe
			44550-2	LOINC		Positive (qualifier value)
			10828004	SNOMEDCT		Detected (qualifier value)
			260373001	SNOMEDCT		Negative (qualifier value)
			260385009	SNOMEDCT		Not detected (qualifier value)
			260415000	SNOMEDCT		Equivocal (qualifier value)
			42425007	SNOMEDCT		Indeterminate (qualifier value)
15	Human papilloma virus rRNA	Y	82334004	SNOMEDCT	Human papilloma virus rRNA [Presence] in Genital specimen by NAA with probe detection
			6514-4	LOINC		Positive (qualifier value)
			10828004	SNOMEDCT		Detected (qualifier value)
			260373001	SNOMEDCT		Negative (qualifier value)
			260385009	SNOMEDCT		Not detected (qualifier value)
			260415000	SNOMEDCT		Equivocal (qualifier value)
			42425007	SNOMEDCT		Indeterminate (qualifier value)
16	Human papilloma virus rRNA	Y	82334004	SNOMEDCT	Human papilloma virus rRNA [Presence] in Unspecified specimen by NAA with probe detection
			6516-9	LOINC		Positive (qualifier value)
			10828004	SNOMEDCT		Detected (qualifier value)
			260373001	SNOMEDCT		Negative (qualifier value)
			260385009	SNOMEDCT		Not detected (qualifier value)
			260415000	SNOMEDCT		Equivocal (qualifier value)
			42425007	SNOMEDCT		Indeterminate (qualifier value)
			82334004	SNOMEDCT

Sheet 5: Chlamydia Tests Panel (86659-0)

Data Element #	FPAR 2.0 Term	In FPAR Panel (86636-8)?	Available Term Code (If Available)	Term Code System	Definition	Value Set (Response Options/Answer Lists)	Notes
-	Chlamydia sp tests - FPAR 2.0 set (PANEL)	Y	86659-0	LOINC	Set of lab terms that may be used to gather Chlamydia trachomatis test results at time of the patient encounter as specified by the Family Planning Annual Report (FPAR).	-	LOINC Panels are collections of LOINC terms that represent specific sets of information, such as a laboratory battery of tests, a group of findings from a procedure such as an EKG, and forms or assessments related to health that are completed by patients and/or providers. LOINC Panels contain a specific structure, and depending on the type of panel, can include attributes such as form coding instructions, skip logic, and nested panels.
1	Chlamydia trachomatis DNA [Units/volume] in Unspecified specimen by Probe and target amplification method	Y	49096-1	LOINC	Chlamydia trachomatis DNA [Units/volume] in Unspecified specimen by NAA with probe detection	(Not applicable. Quantitative lab)
	Chlamydia trachomatis rRNA [Presence] in Unspecified specimen by Probe and target amplification method		43304-5	SNOMEDCT	Chlamydia trachomatis rRNA [Presence] in Unspecified specimen by NAA with probe detection
			260373001	SNOMEDCT		Detected (qualifier value)
		Y	260415000	SNOMEDCT		Not detected (qualifier value)
			419984006	SNOMEDCT		Inconclusive (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
2	Chlamydia trachomatis DNA [Presence] in Urethra by Probe and target amplification method	Y	21191-2	LOINC	Chlamydia trachomatis DNA [Presence] in Urethra by NAA with probe detection
			10828004	SNOMEDCT		Positive (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
3	Chlamydia trachomatis rRNA [Presence] in Unspecified specimen by DNA probe	Y	4993-2	LOINC	Chlamydia trachomatis rRNA [Presence] in Unspecified specimen by Probe
			10828004	SNOMEDCT		Positive (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
4	Chlamydia trachomatis rRNA [Presence] in Genital specimen by DNA probe	Y	16600-9	LOINC	Chlamydia trachomatis rRNA [Presence] in Genital specimen by Probe
			10828004	SNOMEDCT		Positive (qualifier value)
			260373001	SNOMEDCT		Detected (qualifier value)
		Y	260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
		Y	82334004	SNOMEDCT		Indeterminate (qualifier value)
5	Chlamydia trachomatis rRNA [Presence] in Urine by DNA probe		16601-7	LOINC	Chlamydia trachomatis rRNA [Presence] in Urine by Probe
			10828004	SNOMEDCT		Positive (qualifier value)
		Y	260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
6	Chlamydia trachomatis DNA [Presence] in Cervical mucus by Probe and target amplification method		21189-6	LOINC	Chlamydia trachomatis DNA [Presence] in Cervical mucus by NAA with probe detection
			10828004	SNOMEDCT		Positive (qualifier value)
		Y	260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
7	Chlamydia trachomatis DNA [Presence] in Cervix by Probe and target amplification method		21190-4	LOINC	Chlamydia trachomatis DNA [Presence] in Cervix by NAA with probe detection
			10828004	SNOMEDCT		Positive (qualifier value)
		Y	260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
8	Chlamydia trachomatis rRNA [Presence] in Urethra by DNA probe		21192-0	LOINC	Chlamydia trachomatis rRNA [Presence] in Urethra by Probe
			10828004	SNOMEDCT		Positive (qualifier value)
		Y	260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
9	Chlamydia trachomatis DNA [Presence] in Unspecified specimen by Probe and target amplification method		21613-5	LOINC	Chlamydia trachomatis DNA [Presence] in Unspecified specimen by NAA with probe detection
			10828004	SNOMEDCT		Positive (qualifier value)
		Y	260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
10	Chlamydia trachomatis rRNA [Presence] in Genital fluid by DNA probe		23838-6	LOINC	Chlamydia trachomatis rRNA [Presence] in Genital fluid by Probe
			10828004	SNOMEDCT		Positive (qualifier value)
		Y	260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
11	Chlamydia sp DNA [Presence] in Unspecified specimen by Probe and target amplification method		35729-3	LOINC	Chlamydia sp DNA [Presence] in Unspecified specimen by NAA with probe detection
			10828004	SNOMEDCT		Positive (qualifier value)
		Y	260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
12	Chlamydia trachomatis rRNA [Presence] in Urine by Probe and target amplification method		42931-6	LOINC	Chlamydia trachomatis rRNA [Presence] in Urine by NAA with probe detection
			10828004	SNOMEDCT		Positive (qualifier value)
		Y	260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
13	Chlamydia trachomatis DNA [Presence] in Unspecified specimen by Probe and signal amplification method		43404-3	LOINC	Chlamydia trachomatis DNA [Presence] in Unspecified specimen by Probe with signal amplification
			10828004	SNOMEDCT		Positive (qualifier value)
		Y	260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
14	Chlamydia trachomatis rRNA [Presence] in Cervix by DNA probe	Y	45078-3	LOINC	Chlamydia trachomatis rRNA [Presence] in Cervix by Probe
			10828004	SNOMEDCT		Positive (qualifier value)
			260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
15	Chlamydia trachomatis rRNA [Presence] in Vaginal fluid by DNA probe	Y	45080-9	LOINC	Chlamydia trachomatis rRNA [Presence] in Vaginal fluid by Probe
			10828004	SNOMEDCT		Positive (qualifier value)
			260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
16	Chlamydia trachomatis DNA [Presence] in Vaginal fluid by Probe and target amplification method	Y	45084-1	LOINC	Chlamydia trachomatis DNA [Presence] in Vaginal fluid by NAA with probe detection
			10828004	SNOMEDCT		Positive (qualifier value)
			260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
17	Chlamydia trachomatis L2 DNA [Presence] in Unspecified specimen by Probe and target amplification method	Y	47211-8	LOINC	Chlamydia trachomatis L2 DNA [Presence] in Unspecified specimen by NAA with probe detection
			10828004	SNOMEDCT		Positive (qualifier value)
			260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
18	Chlamydia trachomatis DNA [Identifier] in Unspecified specimen by Probe and target amplification method.	Y	47212-6	LOINC	Chlamydia trachomatis DNA [Identifier] in Unspecified specimen by NAA with probe detection
			10828004	SNOMEDCT		Positive (qualifier value)
			260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
19	Chlamydia trachomatis rRNA [Presence] in Cervix by Probe and target amplification method	Y	50387-0	LOINC	Chlamydia trachomatis rRNA [Presence] in Cervix by NAA with probe detection
			10828004	SNOMEDCT		Positive (qualifier value)
			260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
20	Chlamydia trachomatis rRNA [Presence] in Urethra by Probe and target amplification method	Y	53925-4	LOINC	Chlamydia trachomatis rRNA [Presence] in Urethra by NAA with probe detection
			10828004	SNOMEDCT		Positive (qualifier value)
			260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
21	Chlamydia trachomatis rRNA [Presence] in Vaginal fluid by Probe and target amplification method	Y	53926-2	LOINC	Chlamydia trachomatis rRNA [Presence] in Vaginal fluid by NAA with probe detection
			10828004	SNOMEDCT		Positive (qualifier value)
			260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
22	Chlamydia trachomatis DNA [Presence] in Genital specimen by Probe and target amplification method	Y	6356-0	LOINC	Chlamydia trachomatis DNA [Presence] in Genital specimen by NAA with probe detection
			10828004	SNOMEDCT		Positive (qualifier value)
			260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
23	Chlamydia trachomatis DNA [Presence] in Urine by Probe and target amplification method	Y	6357-8	LOINC	Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
			10828004	SNOMEDCT		Positive (qualifier value)
			260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)

Sheet 6: Neis. Gonorrhea Panel (86660-8)

Data Element #	Neisseria Gonorrhoeae Tests Panel	In FPAR Panel?	Data Element Code	Standard Terminology Code System	Term Description	Answer List Name / Description (Value Set)	Notes
-	Neisseria Gonorrhoeae Tests - FPAR 2.0 set	Y	86660-8	LOINC	Set of lab terms that may be used to gather Neisseria gonorrhoeae test results at time of the patient encounter as specified by the Family Planning Annual Report (FPAR).	-
1	Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen by Probe and target amplification method	Y	43305-2	LOINC	Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen by NAA with probe detection
			260373001	SNOMEDCT		Detected (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			419984006	SNOMEDCT		Inconclusive (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
2	Neisseria gonorrhoeae DNA [Presence] in Urethra by Probe and target amplification method	Y	21415-5	LOINC	Neisseria gonorrhoeae DNA [Presence] in Urethra by NAA with probe detection
			10828004	SNOMEDCT		Positive (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
3	Neisseria gonorrhoeae DNA [Presence] in Genital specimen by Probe and target amplification method	Y	47387-6	LOINC	Neisseria gonorrhoeae DNA [Presence] in Genital specimen by NAA with probe detection
			10828004	SNOMEDCT		Positive (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
	Neisseria gonorrhoeae rRNA [Presence] in Cervix by Probe and target amplification method	Y	50388-8	LOINC	Neisseria gonorrhoeae rRNA [Presence] in Cervix by NAA with probe detection
			10828004	SNOMEDCT		Positive (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
4	Neisseria gonorrhoeae DNA [Presence] in Cervical mucus by Probe and target amplification method	Y	21414-8	LOINC	Neisseria gonorrhoeae DNA [Presence] in Cervical mucus by NAA with probe detection
			10828004	SNOMEDCT		Positive (qualifier value)
			260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
5	Neisseria gonorrhoeae DNA [Presence] in Urine by Probe and target amplification method	Y	21416-3	LOINC	Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
			10828004	SNOMEDCT		Positive (qualifier value)
			260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
6	Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by Probe and target amplification method	Y	24111-7	LOINC	Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by NAA with probe detection
			10828004	SNOMEDCT		Positive (qualifier value)
			260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
7	Neisseria gonorrhoeae rRNA [Presence] in Cervix by DNA probe	Y	32198-4	LOINC	Neisseria gonorrhoeae rRNA [Presence] in Cervix by Probe
			10828004	SNOMEDCT		Positive (qualifier value)
			260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
8	Neisseria gonorrhoeae rRNA [Presence] in Urethra by DNA probe	Y	32199-2	LOINC	Neisseria gonorrhoeae rRNA [Presence] in Urethra by Probe
			10828004	SNOMEDCT		Positive (qualifier value)
			260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
9	Neisseria gonorrhoeae DNA [Presence] in Vaginal fluid by Probe and target amplification method	Y	32705-6	LOINC	Neisseria gonorrhoeae DNA [Presence] in Vaginal fluid by NAA with probe detection
			10828004	SNOMEDCT		Positive (qualifier value)
			260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
10	Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by Probe and signal amplification method	Y	43403-5	LOINC	Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by Probe with signal amplification
			10828004	SNOMEDCT		Positive (qualifier value)
			260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
11	Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen by DNA probe	Y	5028-6	LOINC	Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen by Probe
			10828004	SNOMEDCT		Positive (qualifier value)
			260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
12	Neisseria gonorrhoeae rRNA [Presence] in Vaginal fluid by Probe and target amplification method	Y	53879-3	LOINC	Neisseria gonorrhoeae rRNA [Presence] in Vaginal fluid by NAA with probe detection
			10828004	SNOMEDCT		Positive (qualifier value)
			260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
13	Neisseria gonorrhoeae rRNA [Presence] in Urethra by Probe and target amplification method	Y	53927-0	LOINC	Neisseria gonorrhoeae rRNA [Presence] in Urethra by NAA with probe detection
			10828004	SNOMEDCT		Positive (qualifier value)
			260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
14	Neisseria gonorrhoeae Ag [Presence] in Genital specimen by Immunoassay	Y	6487-3	LOINC	Neisseria gonorrhoeae Ag [Presence] in Genital specimen by Immunoassay
			10828004	SNOMEDCT		Positive (qualifier value)
			260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
15	Neisseria gonorrhoeae [Presence] in Cervix by Organism specific culture	Y	688-2	LOINC	Neisseria gonorrhoeae [Presence] in Cervix by Organism specific culture
			10828004	SNOMEDCT		Positive (qualifier value)
			260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
16	Neisseria gonorrhoeae [Presence] in Genital specimen by Organism specific culture	Y	691-6	LOINC	Neisseria gonorrhoeae [Presence] in Genital specimen by Organism specific culture
			10828004	SNOMEDCT		Positive (qualifier value)
			260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
17	Neisseria gonorrhoeae [Presence] in Genital lochia by Organism specific culture	Y	692-4	LOINC	Neisseria gonorrhoeae [Presence] in Genital lochia by Organism specific culture
			10828004	SNOMEDCT		Positive (qualifier value)
			260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
18	Neisseria gonorrhoeae [Presence] in Vaginal fluid by Organism specific culture	Y	693-2	LOINC	Neisseria gonorrhoeae [Presence] in Vaginal fluid by Organism specific culture
			10828004	SNOMEDCT		Positive (qualifier value)
			260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)
19	Neisseria gonorrhoeae [Presence] in Unspecified specimen by Organism specific culture	Y	698-1	LOINC	Neisseria gonorrhoeae [Presence] in Unspecified specimen by Organism specific culture
			10828004	SNOMEDCT		Positive (qualifier value)
			260373001	SNOMEDCT		Detected (qualifier value)
			260385009	SNOMEDCT		Negative (qualifier value)
			260415000	SNOMEDCT		Not detected (qualifier value)
			42425007	SNOMEDCT		Equivocal (qualifier value)
			82334004	SNOMEDCT		Indeterminate (qualifier value)

Sheet 7: CT+NG Com Tests Panel (86661-6)

Data Element #	FPAR 2.0 Term	In FPAR Panel (86636-8)?	Available Term Code (If Available)	Term Code System	Definition	Value Set (Response Options/Answer Lists)	Notes
-	Chlamydia trachomatis+Neisseria gonorrhoeae tests - FPAR 2.0 set	Y	86661-6	LOINC	Set of lab terms that may be used to gather Chlamydia trachomatis and Neisseria gonorrhoeae combined test results at time of the patient encounter as specified by the Family Planning Annual Report (FPAR).		LOINC Panels are collections of LOINC terms that represent specific sets of information, such as a laboratory battery of tests, a group of findings from a procedure such as an EKG, and forms or assessments related to health that are completed by patients and/or providers. LOINC Panels contain a specific structure, and depending on the type of panel, can include attributes such as form coding instructions, skip logic, and nested panels.
1	Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by Probe and target amplification method	Y	36902-5	LOINC	Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by NAA with probe detection	Detected
			260373001	SNOMEDCT		Not detected (qualifier value)
			260415000	SNOMEDCT
2	Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Identifier] in Unspecified specimen by Probe and target amplification method	Y	36903-3	LOINC	Chlamydia trachomatis and Neisseria gonorrhoeae DNA [Identifier] in Unspecified specimen by NAA with probe detection	Positive (qualifier value)
			10828004	SNOMEDCT		Detected (qualifier value)
			260373001	SNOMEDCT		Negative (qualifier value)
			260385009	SNOMEDCT		Not detected (qualifier value)
			260415000	SNOMEDCT		Equivocal (qualifier value)
			42425007	SNOMEDCT		Indeterminate (qualifier value)
			82334004	SNOMEDCT
3	Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by Probe and signal amplification method	Y	43406-8	LOINC	Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by Probe with signal amplification	Positive (qualifier value)
			10828004	SNOMEDCT		Detected (qualifier value)
			260373001	SNOMEDCT		Negative (qualifier value)
			260385009	SNOMEDCT		Not detected (qualifier value)
			260415000	SNOMEDCT		Equivocal (qualifier value)
			42425007	SNOMEDCT		Indeterminate (qualifier value)
			82334004	SNOMEDCT
4	Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Urine by Probe and target amplification method	Y	44806-8	LOINC	Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection	Positive (qualifier value)
			10828004	SNOMEDCT		Detected (qualifier value)
			260373001	SNOMEDCT		Negative (qualifier value)
			260385009	SNOMEDCT		Not detected (qualifier value)
			260415000	SNOMEDCT		Equivocal (qualifier value)
			42425007	SNOMEDCT		Indeterminate (qualifier value)
			82334004	SNOMEDCT
5	Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Genital specimen by Probe and target amplification method	Y	44807-6	LOINC	Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection	Positive (qualifier value)
			10828004	SNOMEDCT		Detected (qualifier value)
			260373001	SNOMEDCT		Negative (qualifier value)
			260385009	SNOMEDCT		Not detected (qualifier value)
			260415000	SNOMEDCT		Equivocal (qualifier value)
			42425007	SNOMEDCT		Indeterminate (qualifier value)
			82334004	SNOMEDCT
6	Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Cervix by DNA probe	Y	45067-6	LOINC	Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Cervix by Probe	Positive (qualifier value)
			10828004	SNOMEDCT		Detected (qualifier value)
			260373001	SNOMEDCT		Negative (qualifier value)
			260385009	SNOMEDCT		Not detected (qualifier value)
			260415000	SNOMEDCT		Equivocal (qualifier value)
			42425007	SNOMEDCT		Indeterminate (qualifier value)
			82334004	SNOMEDCT
7	Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Cervix by Probe and target amplification method	Y	45068-4	LOINC	Chlamydia trachomatis+Neisseria gonorrhoeae DNA [Presence] in Cervix by NAA with probe detection	Positive (qualifier value)
			10828004	SNOMEDCT		Detected (qualifier value)
			260373001	SNOMEDCT		Negative (qualifier value)
			260385009	SNOMEDCT		Not detected (qualifier value)
			260415000	SNOMEDCT		Equivocal (qualifier value)
			42425007	SNOMEDCT		Indeterminate (qualifier value)
			82334004	SNOMEDCT
8	Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Genital specimen by DNA probe	Y	45069-2	LOINC	Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Genital specimen by Probe	Positive (qualifier value)
			10828004	SNOMEDCT		Detected (qualifier value)
			260373001	SNOMEDCT		Negative (qualifier value)
			260385009	SNOMEDCT		Not detected (qualifier value)
			260415000	SNOMEDCT		Equivocal (qualifier value)
			42425007	SNOMEDCT		Indeterminate (qualifier value)
			82334004	SNOMEDCT
9	Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Vaginal fluid by DNA probe	Y	45070-0	LOINC	Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Vaginal fluid by Probe	Positive (qualifier value)
			10828004	SNOMEDCT		Detected (qualifier value)
			260373001	SNOMEDCT		Negative (qualifier value)
			260385009	SNOMEDCT		Not detected (qualifier value)
			260415000	SNOMEDCT		Equivocal (qualifier value)
			42425007	SNOMEDCT		Indeterminate (qualifier value)
			82334004	SNOMEDCT
10	Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Urine by DNA probe	Y	45074-2	LOINC	Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Urine by Probe	Positive (qualifier value)
			10828004	SNOMEDCT		Detected (qualifier value)
			260373001	SNOMEDCT		Negative (qualifier value)
			260385009	SNOMEDCT		Not detected (qualifier value)
			260415000	SNOMEDCT		Equivocal (qualifier value)
			42425007	SNOMEDCT		Indeterminate (qualifier value)
			82334004	SNOMEDCT

11	Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen by DNA probe	Y	45076-7	LOINC	Chlamydia trachomatis+Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen by Probe	Positive (qualifier value)
			10828004	SNOMEDCT		Detected (qualifier value)
			260373001	SNOMEDCT		Negative (qualifier value)
			260385009	SNOMEDCT		Not detected (qualifier value)
			260415000	SNOMEDCT		Equivocal (qualifier value)
			42425007	SNOMEDCT		Indeterminate (qualifier value)
			82334004	SNOMEDCT

Sheet 8: HIV 1 & 2 Tests Panel (86657-4)

Data Element #	FPAR 2.0 Term	In FPAR Panel (86636-8)?	Available Term Code (If Available)	Term Code System	Definition	Value Set (Response Options/Answer Lists)	Notes
	HIV 1 and 2 tests - FPAR 2.0 set (PANEL)	Y	86657-4	LOINC	Set of lab terms that may be used to gather HIV 1 & 2 test results at time of the patient encounter as specified by the Family Planning Annual Report (FPAR).	-	LOINC Panels are collections of LOINC terms that represent specific sets of information, such as a laboratory battery of tests, a group of findings from a procedure such as an EKG, and forms or assessments related to health that are completed by patients and/or providers. LOINC Panels contain a specific structure, and depending on the type of panel, can include attributes such as form coding instructions, skip logic, and nested panels.
1	HIV 1 RNA [Presence] in Unspecified specimen by Probe and target amplification method	Y	5018-7	LOINC	HIV 1 RNA [Presence] in Unspecified specimen by NAA with probe detection	HIV 1 RNA [Presence] in Unspecified specimen by NAA with probe detection
			260373001	SNOMEDCT
			260415000	SNOMEDCT
			82334004	SNOMEDCT
2	HIV 1 Ab [Presence] in Serum by Immunoblot (IB)	Y	5221-7	LOINC	HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot	HIV 1 Ab [Presence] in Serum or Plasma by Immunoblot
			10828004	SNOMEDCT
			260385009	SNOMEDCT
			419984006	SNOMEDCT
			42425007	SNOMEDCT
3	HIV 1 Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay	Y	68961-2	LOINC	HIV 1 Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay	HIV 1 Ab [Presence] in Serum, Plasma or Blood by Rapid immunoassay
			11214006	SNOMEDCT
			131194007	SNOMEDCT
			82334004	SNOMEDCT
4	HIV 2 Ab [Presence] in Serum by Immunoassay\|HIV 2 Ab [Presence] in Serum or Plasma by Immunoassay	Y	30361-0	LOINC	HIV 2 Ab [Presence] in Serum or Plasma by Immunoassay	HIV 2 Ab [Presence] in Serum or Plasma by Immunoassay
			11214006	SNOMEDCT
			131194007	SNOMEDCT
			82334004	SNOMEDCT
5	HIV 1+2 Ab [Presence] in Serum by Immunoassay\|HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay	Y	31201-7	LOINC	HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay	HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay
			10828004	SNOMEDCT
			260385009	SNOMEDCT
6	HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 1.7 log copies/mL	Y	48510-2	LOINC	HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 1.7 log copies/m	HIV 1 RNA [Log #/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 1.7 log copies/m
7	HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 copies/mL	Y	48511-0	LOINC	HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 copies/mL	HIV 1 RNA [#/volume] (viral load) in Serum or Plasma by Probe and target amplification method detection limit = 50 copies/mL


	Supplemental/Confirmatory HIV test
	Rapid/Screening HIV test

File Type	application/vnd.openxmlformats-officedocument.spreadsheetml.sheet
File Modified	0000-00-00
File Created	0000-00-00